# Impact of Probiotic (UltraFlora® Triplebiotic) on Weight Evolution on People After Discontinuation of GLP-1 Treatment.

> **NCT07209046** · NA · NOT_YET_RECRUITING · sponsor: **Metagenics, Inc.** · enrollment: 128 (estimated)

## Conditions studied

- Adults
- GLP-1

## Interventions

- **DIETARY_SUPPLEMENT:** UltraFlora® Triplebiotic
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07209046
- **Lead sponsor:** Metagenics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-07-31
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07209046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07209046, "Impact of Probiotic (UltraFlora® Triplebiotic) on Weight Evolution on People After Discontinuation of GLP-1 Treatment.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07209046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*